CA2483980C

CA2483980C - Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands

Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands Download PDF

Info

Publication number: CA2483980C
Authority: CA; Canada
Prior art keywords: neurons; vector; polypeptide; bbb; blood
Prior art date: 2002-04-26
Legal status : Expired - Fee Related

Application number

CA2483980A

Other languages

English (en)

French (fr)

Other versions

CA2483980A1 (en

Inventor

Ian A. Ferguson

Hiroaki Tani

Current Assignee

Individual

Original Assignee

Individual

Priority date

2002-04-26

Filing date

2003-04-28

Publication date

2013-07-16

2002-04-26 Priority claimed from AUPS1935A external-priority patent/AUPS193502A0/en

2002-07-02 Priority claimed from US10/188,184 external-priority patent/US20030083299A1/en

2003-04-28 Application filed by Individual filed Critical Individual

2003-11-06 Publication of CA2483980A1 publication Critical patent/CA2483980A1/en

2013-07-16 Application granted granted Critical

2013-07-16 Publication of CA2483980C publication Critical patent/CA2483980C/en

2023-04-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 385
102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 374
229920001184 polypeptide Polymers 0.000 title claims abstract description 373
210000001218 blood-brain barrier Anatomy 0.000 title claims abstract description 197
230000008499 blood brain barrier function Effects 0.000 title claims abstract description 196
239000003446 ligand Substances 0.000 title claims description 191
230000001159 endocytotic effect Effects 0.000 title claims description 92
238000001727 in vivo Methods 0.000 title claims description 18
210000002569 neuron Anatomy 0.000 claims abstract description 415
238000000034 method Methods 0.000 claims abstract description 299
239000013598 vector Substances 0.000 claims abstract description 279
108090000623 proteins and genes Proteins 0.000 claims abstract description 249
210000003169 central nervous system Anatomy 0.000 claims abstract description 128
230000002068 genetic effect Effects 0.000 claims abstract description 128
230000008569 process Effects 0.000 claims abstract description 112
241001465754 Metazoa Species 0.000 claims abstract description 88
230000001537 neural effect Effects 0.000 claims abstract description 84
210000002161 motor neuron Anatomy 0.000 claims abstract description 79
230000032258 transport Effects 0.000 claims abstract description 58
210000001044 sensory neuron Anatomy 0.000 claims abstract description 37
230000028327 secretion Effects 0.000 claims abstract description 33
230000007441 retrograde transport Effects 0.000 claims abstract description 19
230000002124 endocrine Effects 0.000 claims abstract description 15
230000003076 paracrine Effects 0.000 claims abstract description 14
208000015122 neurodegenerative disease Diseases 0.000 claims abstract description 12
210000004027 cell Anatomy 0.000 claims description 281
210000001519 tissue Anatomy 0.000 claims description 112
108010025020 Nerve Growth Factor Proteins 0.000 claims description 106
102000005962 receptors Human genes 0.000 claims description 105
108020003175 receptors Proteins 0.000 claims description 105
102000004169 proteins and genes Human genes 0.000 claims description 54
241000282414 Homo sapiens Species 0.000 claims description 47
230000014509 gene expression Effects 0.000 claims description 47
210000001517 olfactory receptor neuron Anatomy 0.000 claims description 46
239000013603 viral vector Substances 0.000 claims description 44
238000009739 binding Methods 0.000 claims description 40
239000000835 fiber Substances 0.000 claims description 40
230000001225 therapeutic effect Effects 0.000 claims description 40
230000027455 binding Effects 0.000 claims description 35
102000007072 Nerve Growth Factors Human genes 0.000 claims description 34
239000003814 drug Substances 0.000 claims description 32
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
208000014674 injury Diseases 0.000 claims description 25
239000003900 neurotrophic factor Substances 0.000 claims description 25
238000001890 transfection Methods 0.000 claims description 24
230000006378 damage Effects 0.000 claims description 23
108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 20
102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 20
230000003612 virological effect Effects 0.000 claims description 19
208000027418 Wounds and injury Diseases 0.000 claims description 18
230000001927 transneuronal effect Effects 0.000 claims description 17
208000006011 Stroke Diseases 0.000 claims description 16
238000002360 preparation method Methods 0.000 claims description 15
208000015114 central nervous system disease Diseases 0.000 claims description 14
201000010099 disease Diseases 0.000 claims description 14
230000000574 ganglionic effect Effects 0.000 claims description 14
102000007339 Nerve Growth Factor Receptors Human genes 0.000 claims description 13
210000004369 blood Anatomy 0.000 claims description 12
239000008280 blood Substances 0.000 claims description 12
239000000463 material Substances 0.000 claims description 12
239000002858 neurotransmitter agent Substances 0.000 claims description 12
208000024827 Alzheimer disease Diseases 0.000 claims description 11
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 11
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 11
108050002069 Olfactory receptors Proteins 0.000 claims description 11
108010032605 Nerve Growth Factor Receptors Proteins 0.000 claims description 10
102000012547 Olfactory receptors Human genes 0.000 claims description 10
125000002091 cationic group Chemical group 0.000 claims description 10
239000003102 growth factor Substances 0.000 claims description 10
208000012902 Nervous system disease Diseases 0.000 claims description 9
230000008901 benefit Effects 0.000 claims description 9
210000004962 mammalian cell Anatomy 0.000 claims description 9
230000000295 complement effect Effects 0.000 claims description 8
150000002632 lipids Chemical class 0.000 claims description 8
208000029028 brain injury Diseases 0.000 claims description 7
206010021143 Hypoxia Diseases 0.000 claims description 6
230000006931 brain damage Effects 0.000 claims description 6
210000000234 capsid Anatomy 0.000 claims description 6
231100000874 brain damage Toxicity 0.000 claims description 5
230000001146 hypoxic effect Effects 0.000 claims description 5
239000002502 liposome Substances 0.000 claims description 5
208000010496 Heart Arrest Diseases 0.000 claims description 4
208000018737 Parkinson disease Diseases 0.000 claims description 4
230000002990 hypoglossal effect Effects 0.000 claims description 4
230000000302 ischemic effect Effects 0.000 claims description 4
206010003497 Asphyxia Diseases 0.000 claims description 3
101710166569 Olfactory marker protein Proteins 0.000 claims description 3
108010076533 Glycine Receptors Proteins 0.000 claims description 2
208000023105 Huntington disease Diseases 0.000 claims description 2
208000015439 Lysosomal storage disease Diseases 0.000 claims description 2
208000006079 Near drowning Diseases 0.000 claims description 2
102000057128 Olfactory Marker Human genes 0.000 claims description 2
208000005264 motor neuron disease Diseases 0.000 claims description 2
230000000626 neurodegenerative effect Effects 0.000 claims description 2
210000001002 parasympathetic nervous system Anatomy 0.000 claims description 2
239000002243 precursor Substances 0.000 claims description 2
208000020431 spinal cord injury Diseases 0.000 claims description 2
210000002820 sympathetic nervous system Anatomy 0.000 claims description 2
102000055006 Calcitonin Human genes 0.000 claims 1
108060001064 Calcitonin Proteins 0.000 claims 1
102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims 1
108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims 1
102100029740 Poliovirus receptor Human genes 0.000 claims 1
239000000556 agonist Substances 0.000 claims 1
239000005557 antagonist Substances 0.000 claims 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 1
229960004015 calcitonin Drugs 0.000 claims 1
238000012637 gene transfection Methods 0.000 claims 1
201000010901 lateral sclerosis Diseases 0.000 claims 1
108010048507 poliovirus receptor Proteins 0.000 claims 1
210000004556 brain Anatomy 0.000 abstract description 69
238000011282 treatment Methods 0.000 abstract description 55
238000013459 approach Methods 0.000 abstract description 50
230000000694 effects Effects 0.000 abstract description 49
210000005056 cell body Anatomy 0.000 abstract description 43
210000005036 nerve Anatomy 0.000 abstract description 38
230000006870 function Effects 0.000 abstract description 25
230000002093 peripheral effect Effects 0.000 abstract description 23
208000004296 neuralgia Diseases 0.000 abstract description 21
208000021722 neuropathic pain Diseases 0.000 abstract description 21
241000894007 species Species 0.000 abstract description 15
230000004770 neurodegeneration Effects 0.000 abstract description 14
230000012010 growth Effects 0.000 abstract description 12
230000001976 improved effect Effects 0.000 abstract description 12
230000001771 impaired effect Effects 0.000 abstract description 9
244000144972 livestock Species 0.000 abstract description 7
230000035800 maturation Effects 0.000 abstract description 4
230000001850 reproductive effect Effects 0.000 abstract description 3
102000015336 Nerve Growth Factor Human genes 0.000 description 72
238000012360 testing method Methods 0.000 description 70
108020004414 DNA Proteins 0.000 description 62
150000001875 compounds Chemical class 0.000 description 50
241000700605 Viruses Species 0.000 description 48
210000000278 spinal cord Anatomy 0.000 description 45
235000018102 proteins Nutrition 0.000 description 42
239000002245 particle Substances 0.000 description 41
238000012750 in vivo screening Methods 0.000 description 40
230000012202 endocytosis Effects 0.000 description 36
210000003497 sciatic nerve Anatomy 0.000 description 35
241000700159 Rattus Species 0.000 description 34
101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 34
238000012216 screening Methods 0.000 description 33
238000011160 research Methods 0.000 description 31
210000003050 axon Anatomy 0.000 description 29
108020004999 messenger RNA Proteins 0.000 description 29
210000004498 neuroglial cell Anatomy 0.000 description 29
238000002823 phage display Methods 0.000 description 29
208000002193 Pain Diseases 0.000 description 28
210000004129 prosencephalon Anatomy 0.000 description 28
230000036407 pain Effects 0.000 description 23
238000010353 genetic engineering Methods 0.000 description 22
229940079593 drug Drugs 0.000 description 21
210000004126 nerve fiber Anatomy 0.000 description 21
102000053602 DNA Human genes 0.000 description 20
241000699670 Mus sp. Species 0.000 description 20
241000282412 Homo Species 0.000 description 19
210000002932 cholinergic neuron Anatomy 0.000 description 19
229940088597 hormone Drugs 0.000 description 19
239000005556 hormone Substances 0.000 description 19
108020004705 Codon Proteins 0.000 description 17
239000012634 fragment Substances 0.000 description 17
238000002347 injection Methods 0.000 description 17
239000007924 injection Substances 0.000 description 17
210000003205 muscle Anatomy 0.000 description 17
229940077737 brain-derived neurotrophic factor Drugs 0.000 description 16
230000008878 coupling Effects 0.000 description 16
238000010168 coupling process Methods 0.000 description 16
238000005859 coupling reaction Methods 0.000 description 16
230000001965 increasing effect Effects 0.000 description 16
210000004379 membrane Anatomy 0.000 description 16
239000012528 membrane Substances 0.000 description 16
230000000946 synaptic effect Effects 0.000 description 16
241000701161 unidentified adenovirus Species 0.000 description 15
239000003795 chemical substances by application Substances 0.000 description 14
239000012530 fluid Substances 0.000 description 14
210000003695 paranasal sinus Anatomy 0.000 description 14
239000013612 plasmid Substances 0.000 description 14
210000003491 skin Anatomy 0.000 description 14
125000003275 alpha amino acid group Chemical group 0.000 description 13
239000003153 chemical reaction reagent Substances 0.000 description 13
230000000508 neurotrophic effect Effects 0.000 description 13
230000004044 response Effects 0.000 description 13
108091026890 Coding region Proteins 0.000 description 12
108091028043 Nucleic acid sequence Proteins 0.000 description 12
238000010171 animal model Methods 0.000 description 12
210000000133 brain stem Anatomy 0.000 description 12
210000001787 dendrite Anatomy 0.000 description 12
210000003414 extremity Anatomy 0.000 description 12
239000007788 liquid Substances 0.000 description 12
230000007246 mechanism Effects 0.000 description 12
230000010076 replication Effects 0.000 description 12
208000035475 disorder Diseases 0.000 description 11
238000012377 drug delivery Methods 0.000 description 11
238000011156 evaluation Methods 0.000 description 11
238000001415 gene therapy Methods 0.000 description 11
210000001624 hip Anatomy 0.000 description 11
238000012544 monitoring process Methods 0.000 description 11
108010076504 Protein Sorting Signals Proteins 0.000 description 10
238000004458 analytical method Methods 0.000 description 10
238000000338 in vitro Methods 0.000 description 10
239000003550 marker Substances 0.000 description 10
210000001706 olfactory mucosa Anatomy 0.000 description 10
238000012552 review Methods 0.000 description 10
238000002560 therapeutic procedure Methods 0.000 description 10
206010028980 Neoplasm Diseases 0.000 description 9
235000001014 amino acid Nutrition 0.000 description 9
210000002453 autonomic neuron Anatomy 0.000 description 9
210000001175 cerebrospinal fluid Anatomy 0.000 description 9
239000000601 hypothalamic hormone Substances 0.000 description 9
229940043650 hypothalamic hormone Drugs 0.000 description 9
229940053128 nerve growth factor Drugs 0.000 description 9
230000001817 pituitary effect Effects 0.000 description 9
210000003705 ribosome Anatomy 0.000 description 9
239000000126 substance Substances 0.000 description 9
230000002889 sympathetic effect Effects 0.000 description 9
210000000225 synapse Anatomy 0.000 description 9
239000003981 vehicle Substances 0.000 description 9
108090000565 Capsid Proteins Proteins 0.000 description 8
102100023321 Ceruloplasmin Human genes 0.000 description 8
108010039918 Polylysine Proteins 0.000 description 8
150000001413 amino acids Chemical class 0.000 description 8
239000002585 base Substances 0.000 description 8
230000001713 cholinergic effect Effects 0.000 description 8
238000001802 infusion Methods 0.000 description 8
210000002414 leg Anatomy 0.000 description 8
210000000956 olfactory bulb Anatomy 0.000 description 8
230000001717 pathogenic effect Effects 0.000 description 8
230000001766 physiological effect Effects 0.000 description 8
229920000656 polylysine Polymers 0.000 description 8
238000012545 processing Methods 0.000 description 8
239000000700 radioactive tracer Substances 0.000 description 8
230000001953 sensory effect Effects 0.000 description 8
102000018697 Membrane Proteins Human genes 0.000 description 7
108010052285 Membrane Proteins Proteins 0.000 description 7
102100036220 PC4 and SFRS1-interacting protein Human genes 0.000 description 7
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 7
239000000427 antigen Substances 0.000 description 7
230000000890 antigenic effect Effects 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
210000005013 brain tissue Anatomy 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
230000001413 cellular effect Effects 0.000 description 7
208000015181 infectious disease Diseases 0.000 description 7
230000001524 infective effect Effects 0.000 description 7
239000000203 mixture Substances 0.000 description 7
210000004940 nucleus Anatomy 0.000 description 7
230000010837 receptor-mediated endocytosis Effects 0.000 description 7
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
206010003694 Atrophy Diseases 0.000 description 6
108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
102000018997 Growth Hormone Human genes 0.000 description 6
108010051696 Growth Hormone Proteins 0.000 description 6
101001111439 Homo sapiens Beta-nerve growth factor Proteins 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
239000000232 Lipid Bilayer Substances 0.000 description 6
241000124008 Mammalia Species 0.000 description 6
241000283984 Rodentia Species 0.000 description 6
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 6
229960004373 acetylcholine Drugs 0.000 description 6
230000037444 atrophy Effects 0.000 description 6
201000011510 cancer Diseases 0.000 description 6
238000010276 construction Methods 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
102000046917 human NGF Human genes 0.000 description 6
230000001939 inductive effect Effects 0.000 description 6
230000013016 learning Effects 0.000 description 6
230000008050 pain signaling Effects 0.000 description 6
239000000523 sample Substances 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
238000013519 translation Methods 0.000 description 6
102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 5
241000702421 Dependoparvovirus Species 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 5
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 5
206010019196 Head injury Diseases 0.000 description 5
101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 5
101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 5
101000801237 Rattus norvegicus Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 5
241000700584 Simplexvirus Species 0.000 description 5
108020005202 Viral DNA Proteins 0.000 description 5
230000003466 anti-cipated effect Effects 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
239000011324 bead Substances 0.000 description 5
230000005540 biological transmission Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
230000001276 controlling effect Effects 0.000 description 5
230000001054 cortical effect Effects 0.000 description 5
235000018417 cysteine Nutrition 0.000 description 5
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 5
210000000805 cytoplasm Anatomy 0.000 description 5
238000009826 distribution Methods 0.000 description 5
239000000122 growth hormone Substances 0.000 description 5
230000003054 hormonal effect Effects 0.000 description 5
102000052073 human NGFR Human genes 0.000 description 5
230000001900 immune effect Effects 0.000 description 5
230000002401 inhibitory effect Effects 0.000 description 5
230000001404 mediated effect Effects 0.000 description 5
210000004779 membrane envelope Anatomy 0.000 description 5
230000015654 memory Effects 0.000 description 5
230000002474 noradrenergic effect Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
210000000063 presynaptic terminal Anatomy 0.000 description 5
230000000862 serotonergic effect Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000003356 suture material Substances 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
230000000699 topical effect Effects 0.000 description 5
230000001960 triggered effect Effects 0.000 description 5
241001529453 unidentified herpesvirus Species 0.000 description 5
101710132601 Capsid protein Proteins 0.000 description 4
108010058699 Choline O-acetyltransferase Proteins 0.000 description 4
102100023460 Choline O-acetyltransferase Human genes 0.000 description 4
101710094648 Coat protein Proteins 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
108010049140 Endorphins Proteins 0.000 description 4
102000009025 Endorphins Human genes 0.000 description 4
241000991587 Enterovirus C Species 0.000 description 4
208000003098 Ganglion Cysts Diseases 0.000 description 4
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 4
208000004454 Hyperalgesia Diseases 0.000 description 4
101710125418 Major capsid protein Proteins 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
208000025966 Neurological disease Diseases 0.000 description 4
108090000742 Neurotrophin 3 Proteins 0.000 description 4
102100029268 Neurotrophin-3 Human genes 0.000 description 4
101710141454 Nucleoprotein Proteins 0.000 description 4
229920002873 Polyethylenimine Polymers 0.000 description 4
101710083689 Probable capsid protein Proteins 0.000 description 4
-1 Substance P, enkephalins Chemical class 0.000 description 4
108700026226 TATA Box Proteins 0.000 description 4
230000032683 aging Effects 0.000 description 4
125000000539 amino acid group Chemical group 0.000 description 4
210000004102 animal cell Anatomy 0.000 description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
230000003542 behavioural effect Effects 0.000 description 4
230000017531 blood circulation Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
239000007789 gas Substances 0.000 description 4
210000004907 gland Anatomy 0.000 description 4
238000003306 harvesting Methods 0.000 description 4
239000002303 hypothalamus releasing factor Substances 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
230000030214 innervation Effects 0.000 description 4
230000005015 neuronal process Effects 0.000 description 4
239000002581 neurotoxin Substances 0.000 description 4
231100000618 neurotoxin Toxicity 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
230000035515 penetration Effects 0.000 description 4
210000003635 pituitary gland Anatomy 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
210000005250 spinal neuron Anatomy 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
230000002459 sustained effect Effects 0.000 description 4
230000008685 targeting Effects 0.000 description 4
229940126585 therapeutic drug Drugs 0.000 description 4
230000009261 transgenic effect Effects 0.000 description 4
230000008733 trauma Effects 0.000 description 4
230000008736 traumatic injury Effects 0.000 description 4
208000023275 Autoimmune disease Diseases 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
241000450599 DNA viruses Species 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 3
102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 description 3
206010062767 Hypophysitis Diseases 0.000 description 3
206010061216 Infarction Diseases 0.000 description 3
108090000862 Ion Channels Proteins 0.000 description 3
102000004310 Ion Channels Human genes 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 3
102100038895 Myc proto-oncogene protein Human genes 0.000 description 3
101710135898 Myc proto-oncogene protein Proteins 0.000 description 3
108091008604 NGF receptors Proteins 0.000 description 3
108090000099 Neurotrophin-4 Proteins 0.000 description 3
206010033799 Paralysis Diseases 0.000 description 3
206010037742 Rabies Diseases 0.000 description 3
241000711798 Rabies lyssavirus Species 0.000 description 3
108020004682 Single-Stranded DNA Proteins 0.000 description 3
101710142969 Somatoliberin Proteins 0.000 description 3
208000005400 Synovial Cyst Diseases 0.000 description 3
102000011923 Thyrotropin Human genes 0.000 description 3
108010061174 Thyrotropin Proteins 0.000 description 3
101710150448 Transcriptional regulator Myc Proteins 0.000 description 3
208000036142 Viral infection Diseases 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
230000002567 autonomic effect Effects 0.000 description 3
230000008335 axon cargo transport Effects 0.000 description 3
230000006399 behavior Effects 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
230000007248 cellular mechanism Effects 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
230000006735 deficit Effects 0.000 description 3
230000007850 degeneration Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
230000002964 excitative effect Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
230000004077 genetic alteration Effects 0.000 description 3
231100000118 genetic alteration Toxicity 0.000 description 3
229930195712 glutamate Natural products 0.000 description 3
210000004884 grey matter Anatomy 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
230000008765 hyperinnervation Effects 0.000 description 3
239000000960 hypophysis hormone Substances 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000003364 immunohistochemistry Methods 0.000 description 3
230000007574 infarction Effects 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
238000010255 intramuscular injection Methods 0.000 description 3
239000007927 intramuscular injection Substances 0.000 description 3
230000003902 lesion Effects 0.000 description 3
210000000627 locus coeruleus Anatomy 0.000 description 3
210000003141 lower extremity Anatomy 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000007922 nasal spray Substances 0.000 description 3
210000000653 nervous system Anatomy 0.000 description 3
210000002241 neurite Anatomy 0.000 description 3
230000007514 neuronal growth Effects 0.000 description 3
230000037361 pathway Effects 0.000 description 3
230000008447 perception Effects 0.000 description 3
239000012071 phase Substances 0.000 description 3
230000035479 physiological effects, processes and functions Effects 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
210000003370 receptor cell Anatomy 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000008439 repair process Effects 0.000 description 3
230000033458 reproduction Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
230000003248 secreting effect Effects 0.000 description 3
230000035807 sensation Effects 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
230000008093 supporting effect Effects 0.000 description 3
231100000765 toxin Toxicity 0.000 description 3
239000003053 toxin Substances 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
238000012546 transfer Methods 0.000 description 3
230000001052 transient effect Effects 0.000 description 3
230000003363 transsynaptic effect Effects 0.000 description 3
231100000611 venom Toxicity 0.000 description 3
230000002861 ventricular Effects 0.000 description 3
230000009385 viral infection Effects 0.000 description 3
230000002747 voluntary effect Effects 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
241000271566 Aves Species 0.000 description 2
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 2
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 2
206010010144 Completed suicide Diseases 0.000 description 2
239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 2
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108010092674 Enkephalins Proteins 0.000 description 2
208000035874 Excoriation Diseases 0.000 description 2
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
241000724791 Filamentous phage Species 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
108700007698 Genetic Terminator Regions Proteins 0.000 description 2
208000007514 Herpes zoster Diseases 0.000 description 2
101000736088 Homo sapiens PC4 and SFRS1-interacting protein Proteins 0.000 description 2
208000035154 Hyperesthesia Diseases 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
241000713666 Lentivirus Species 0.000 description 2
241000270322 Lepidosauria Species 0.000 description 2
102000004058 Leukemia inhibitory factor Human genes 0.000 description 2
108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
238000012347 Morris Water Maze Methods 0.000 description 2
101150064037 NGF gene Proteins 0.000 description 2
102000004108 Neurotransmitter Receptors Human genes 0.000 description 2
108090000590 Neurotransmitter Receptors Proteins 0.000 description 2
102000003683 Neurotrophin-4 Human genes 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
206010057249 Phagocytosis Diseases 0.000 description 2
235000014676 Phragmites communis Nutrition 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
241000288906 Primates Species 0.000 description 2
102000003946 Prolactin Human genes 0.000 description 2
108010057464 Prolactin Proteins 0.000 description 2
101000911780 Rattus norvegicus Hsc70-interacting protein Proteins 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
102000005157 Somatostatin Human genes 0.000 description 2
108010056088 Somatostatin Proteins 0.000 description 2
208000020339 Spinal injury Diseases 0.000 description 2
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 2
102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 2
101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 2
102000055135 Vasoactive Intestinal Peptide Human genes 0.000 description 2
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 2
108010046516 Wheat Germ Agglutinins Proteins 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
238000002679 ablation Methods 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
238000001261 affinity purification Methods 0.000 description 2
206010053552 allodynia Diseases 0.000 description 2
210000003403 autonomic nervous system Anatomy 0.000 description 2
230000003376 axonal effect Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000004700 cellular uptake Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
210000004081 cilia Anatomy 0.000 description 2
230000004087 circulation Effects 0.000 description 2
239000000512 collagen gel Substances 0.000 description 2
238000012790 confirmation Methods 0.000 description 2
229940041967 corticotropin-releasing hormone Drugs 0.000 description 2
KLVRDXBAMSPYKH-RKYZNNDCSA-N corticotropin-releasing hormone (human) Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(C)C)C1=CNC=N1 KLVRDXBAMSPYKH-RKYZNNDCSA-N 0.000 description 2
125000004122 cyclic group Chemical group 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
229960003638 dopamine Drugs 0.000 description 2
238000001647 drug administration Methods 0.000 description 2
229940000406 drug candidate Drugs 0.000 description 2
241001493065 dsRNA viruses Species 0.000 description 2
210000001163 endosome Anatomy 0.000 description 2
210000002889 endothelial cell Anatomy 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
230000004927 fusion Effects 0.000 description 2
238000001476 gene delivery Methods 0.000 description 2
230000000762 glandular Effects 0.000 description 2
239000003292 glue Substances 0.000 description 2
210000003128 head Anatomy 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000012606 in vitro cell culture Methods 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
208000028867 ischemia Diseases 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229930027917 kanamycin Natural products 0.000 description 2
229960000318 kanamycin Drugs 0.000 description 2
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
229930182823 kanamycin A Natural products 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
230000007786 learning performance Effects 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000013160 medical therapy Methods 0.000 description 2
230000007334 memory performance Effects 0.000 description 2
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
210000004400 mucous membrane Anatomy 0.000 description 2
210000001087 myotubule Anatomy 0.000 description 2
239000000133 nasal decongestant Substances 0.000 description 2
229940097496 nasal spray Drugs 0.000 description 2
230000000926 neurological effect Effects 0.000 description 2
230000003961 neuronal insult Effects 0.000 description 2
230000002981 neuropathic effect Effects 0.000 description 2
229940032018 neurotrophin 3 Drugs 0.000 description 2
229940097998 neurotrophin 4 Drugs 0.000 description 2
210000000929 nociceptor Anatomy 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
210000001331 nose Anatomy 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
210000003463 organelle Anatomy 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
210000001428 peripheral nervous system Anatomy 0.000 description 2
230000008782 phagocytosis Effects 0.000 description 2
230000035790 physiological processes and functions Effects 0.000 description 2
230000008884 pinocytosis Effects 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
239000000902 placebo Substances 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
229940097325 prolactin Drugs 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
210000001609 raphe nuclei Anatomy 0.000 description 2
230000008929 regeneration Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
230000000284 resting effect Effects 0.000 description 2
238000007790 scraping Methods 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 2
229960000553 somatostatin Drugs 0.000 description 2
125000006850 spacer group Chemical group 0.000 description 2
210000003594 spinal ganglia Anatomy 0.000 description 2
239000007858 starting material Substances 0.000 description 2
230000035882 stress Effects 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
210000002222 superior cervical ganglion Anatomy 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
229940034199 thyrotropin-releasing hormone Drugs 0.000 description 2
210000001578 tight junction Anatomy 0.000 description 2
230000009466 transformation Effects 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
210000000427 trigeminal ganglion Anatomy 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
230000010390 voluntary motor control Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
208000000044 Amnesia Diseases 0.000 description 1
241000239290 Araneae Species 0.000 description 1
206010003571 Astrocytoma Diseases 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
101100222854 Bacillus subtilis (strain 168) czcO gene Proteins 0.000 description 1
241000908115 Bolivar Species 0.000 description 1
206010006784 Burning sensation Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
208000001408 Carbon monoxide poisoning Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
208000001387 Causalgia Diseases 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
208000018663 Central Nervous System Viral disease Diseases 0.000 description 1
241000238366 Cephalopoda Species 0.000 description 1
206010008089 Cerebral artery occlusion Diseases 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
208000000094 Chronic Pain Diseases 0.000 description 1
102000005853 Clathrin Human genes 0.000 description 1
108010019874 Clathrin Proteins 0.000 description 1
102000003712 Complement factor B Human genes 0.000 description 1
108090000056 Complement factor B Proteins 0.000 description 1
208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
206010010254 Concussion Diseases 0.000 description 1
206010010741 Conjunctivitis Diseases 0.000 description 1
101800000414 Corticotropin Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
208000012239 Developmental disease Diseases 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
206010013647 Drowning Diseases 0.000 description 1
206010014612 Encephalitis viral Diseases 0.000 description 1
241000710188 Encephalomyocarditis virus Species 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
241000237858 Gastropoda Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
102000011714 Glycine Receptors Human genes 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
102000015611 Hypothalamic Hormones Human genes 0.000 description 1
108010024118 Hypothalamic Hormones Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
101100537961 Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) trkA2 gene Proteins 0.000 description 1
231100000757 Microbial toxin Toxicity 0.000 description 1
208000026072 Motor neurone disease Diseases 0.000 description 1
101100404651 Mus musculus Ngf gene Proteins 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
206010056677 Nerve degeneration Diseases 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
108090000189 Neuropeptides Proteins 0.000 description 1
102400001103 Neurotensin Human genes 0.000 description 1
101800001814 Neurotensin Proteins 0.000 description 1
101710138657 Neurotoxin Proteins 0.000 description 1
102100033857 Neurotrophin-4 Human genes 0.000 description 1
102000003840 Opioid Receptors Human genes 0.000 description 1
108090000137 Opioid Receptors Proteins 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
208000010886 Peripheral nerve injury Diseases 0.000 description 1
208000004983 Phantom Limb Diseases 0.000 description 1
206010056238 Phantom pain Diseases 0.000 description 1
102000006877 Pituitary Hormones Human genes 0.000 description 1
108010047386 Pituitary Hormones Proteins 0.000 description 1
108010089814 Plant Lectins Proteins 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
108020005067 RNA Splice Sites Proteins 0.000 description 1
238000001069 Raman spectroscopy Methods 0.000 description 1
101100404655 Rattus norvegicus Ngf gene Proteins 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
206010039203 Road traffic accident Diseases 0.000 description 1
108010084592 Saporins Proteins 0.000 description 1
241000270295 Serpentes Species 0.000 description 1
206010040844 Skin exfoliation Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
102400000096 Substance P Human genes 0.000 description 1
101800003906 Substance P Proteins 0.000 description 1
108700025695 Suppressor Genes Proteins 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
108010055044 Tetanus Toxin Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000007238 Transferrin Receptors Human genes 0.000 description 1
108010033576 Transferrin Receptors Proteins 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
208000030886 Traumatic Brain injury Diseases 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
244000290333 Vanilla fragrans Species 0.000 description 1
235000009499 Vanilla fragrans Nutrition 0.000 description 1
235000012036 Vanilla tahitensis Nutrition 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
241000256856 Vespidae Species 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000009056 active transport Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
239000000910 agglutinin Substances 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
230000004075 alteration Effects 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
210000004960 anterior grey column Anatomy 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
206010003074 arachnoiditis Diseases 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
238000003556 assay Methods 0.000 description 1
210000001130 astrocyte Anatomy 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000008275 binding mechanism Effects 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000003851 biochemical process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000002612 cardiopulmonary effect Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
150000001767 cationic compounds Chemical class 0.000 description 1
230000003915 cell function Effects 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
230000004640 cellular pathway Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
229960001117 clenbuterol Drugs 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000001447 compensatory effect Effects 0.000 description 1
208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
230000009514 concussion Effects 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
229960000258 corticotropin Drugs 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
239000000850 decongestant Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000002542 deteriorative effect Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
230000003291 dopaminomimetic effect Effects 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000000598 endocrine disruptor Substances 0.000 description 1
210000000750 endocrine system Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
231100000318 excitotoxic Toxicity 0.000 description 1
230000003492 excitotoxic effect Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
230000035558 fertility Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
238000010304 firing Methods 0.000 description 1
238000007667 floating Methods 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
229940028334 follicle stimulating hormone Drugs 0.000 description 1
235000013305 food Nutrition 0.000 description 1
210000004055 fourth ventricle Anatomy 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
101150082979 gdnf gene Proteins 0.000 description 1
238000012215 gene cloning Methods 0.000 description 1
238000002695 general anesthesia Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000012268 genome sequencing Methods 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229940049906 glutamate Drugs 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
230000001456 gonadotroph Effects 0.000 description 1
229940035638 gonadotropin-releasing hormone Drugs 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
230000000971 hippocampal effect Effects 0.000 description 1
210000001320 hippocampus Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
239000000819 hypertonic solution Substances 0.000 description 1
229940021223 hypertonic solution Drugs 0.000 description 1
239000000815 hypotonic solution Substances 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
238000013101 initial test Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000008316 intracellular mechanism Effects 0.000 description 1
230000010189 intracellular transport Effects 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000003140 lateral ventricle Anatomy 0.000 description 1
230000028252 learning or memory Effects 0.000 description 1
239000002523 lectin Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
238000002690 local anesthesia Methods 0.000 description 1
230000003137 locomotive effect Effects 0.000 description 1
231100000863 loss of memory Toxicity 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000004880 lymph fluid Anatomy 0.000 description 1
210000004324 lymphatic system Anatomy 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000036244 malformation Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000028161 membrane depolarization Effects 0.000 description 1
210000001259 mesencephalon Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
229960001047 methyl salicylate Drugs 0.000 description 1
210000000274 microglia Anatomy 0.000 description 1
201000007309 middle cerebral artery infarction Diseases 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
238000003032 molecular docking Methods 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
230000007659 motor function Effects 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
230000004118 muscle contraction Effects 0.000 description 1
230000003387 muscular Effects 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000035772 mutation Effects 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
210000003928 nasal cavity Anatomy 0.000 description 1
230000005709 nerve cell growth Effects 0.000 description 1
230000010004 neural pathway Effects 0.000 description 1
230000036403 neuro physiology Effects 0.000 description 1
230000003955 neuronal function Effects 0.000 description 1
230000008906 neuronal response Effects 0.000 description 1
230000000324 neuroprotective effect Effects 0.000 description 1
PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 1
230000002276 neurotropic effect Effects 0.000 description 1
230000003040 nociceptive effect Effects 0.000 description 1
108091008700 nociceptors Proteins 0.000 description 1
231100001160 nonlethal Toxicity 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
239000002674 ointment Substances 0.000 description 1
210000004248 oligodendroglia Anatomy 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000001151 other effect Effects 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
238000012856 packing Methods 0.000 description 1
230000008058 pain sensation Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000001734 parasympathetic effect Effects 0.000 description 1
238000011302 passive avoidance test Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
210000000578 peripheral nerve Anatomy 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
230000002399 phagocytotic effect Effects 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
210000004560 pineal gland Anatomy 0.000 description 1
239000003726 plant lectin Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
210000002243 primary neuron Anatomy 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
238000011552 rat model Methods 0.000 description 1
239000002464 receptor antagonist Substances 0.000 description 1
229940044551 receptor antagonist Drugs 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000007670 refining Methods 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000008521 reorganization Effects 0.000 description 1
230000001846 repelling effect Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
210000004994 reproductive system Anatomy 0.000 description 1
230000008458 response to injury Effects 0.000 description 1
230000003938 response to stress Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000003994 retinal ganglion cell Anatomy 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000009291 secondary effect Effects 0.000 description 1
210000003900 secondary neuron Anatomy 0.000 description 1
230000018448 secretion by cell Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000037152 sensory function Effects 0.000 description 1
230000008786 sensory perception of smell Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
230000011664 signaling Effects 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
201000009890 sinusitis Diseases 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000012128 staining reagent Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000003068 static effect Effects 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000005309 stochastic process Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
230000035900 sweating Effects 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
238000010998 test method Methods 0.000 description 1
229940118376 tetanus toxin Drugs 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
229960000874 thyrotropin Drugs 0.000 description 1
230000001748 thyrotropin Effects 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
238000003778 tissue fixation method Methods 0.000 description 1
230000008467 tissue growth Effects 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
101150025395 trkA gene Proteins 0.000 description 1
101150113435 trkA1 gene Proteins 0.000 description 1
230000001228 trophic effect Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
210000001048 venom Anatomy 0.000 description 1
239000002435 venom Substances 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
201000002498 viral encephalitis Diseases 0.000 description 1
230000007482 viral spreading Effects 0.000 description 1
210000004885 white matter Anatomy 0.000 description 1
NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
229960001763 zinc sulfate Drugs 0.000 description 1
229910000368 zinc sulfate Inorganic materials 0.000 description 1